Success Metrics

Clinical Success Rate
87.9%

Based on 58 completed trials

Completion Rate
88%(58/66)
Active Trials
5(6%)
Results Posted
55%(32 trials)
Terminated
8(9%)

Phase Distribution

Ph not_applicable
23
26%
Ph phase_2
21
24%
Ph phase_4
13
15%
Ph early_phase_1
3
3%
Ph phase_1
18
20%
Ph phase_3
11
12%

Phase Distribution

21

Early Stage

21

Mid Stage

24

Late Stage

Phase Distribution89 total trials
Early Phase 1First-in-human
3(3.4%)
Phase 1Safety & dosage
18(20.2%)
Phase 2Efficacy & side effects
21(23.6%)
Phase 3Large-scale testing
11(12.4%)
Phase 4Post-market surveillance
13(14.6%)
N/ANon-phased studies
23(25.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.1%

58 of 69 finished

Non-Completion Rate

15.9%

11 ended early

Currently Active

5

trials recruiting

Total Trials

89

all time

Status Distribution
Active(8)
Completed(58)
Terminated(11)
Other(12)

Detailed Status

Completed58
unknown11
Terminated8
Recruiting5
Not yet recruiting3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
89
Active
5
Success Rate
87.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.4%)
Phase 118 (20.2%)
Phase 221 (23.6%)
Phase 311 (12.4%)
Phase 413 (14.6%)
N/A23 (25.8%)

Trials by Status

not_yet_recruiting33%
withdrawn33%
completed5865%
recruiting56%
terminated89%
unknown1112%
suspended11%

Recent Activity

Clinical Trials (89)

Showing 20 of 89 trialsScroll for more
NCT07452146Phase 2

Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use

Not Yet Recruiting
NCT05089630Phase 1

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Completed
NCT07328906Not Applicable

Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome

Not Yet Recruiting
NCT07171723Phase 1

Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Recruiting
NCT04482621Phase 2

Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial

Suspended
NCT04661839Phase 1

A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults

Completed
NCT04211961Phase 2

Scopolamine in Bipolar Depression

Completed
NCT05695495Phase 1

Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)

Completed
NCT06189001Not Applicable

The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

Completed
NCT05048667Phase 1

Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction

Completed
NCT04046861Not Applicable

Influence of High Vitamin C Dose on Lactate During and After Extracorporeal Circulation

Completed
NCT03505723Phase 3

PeriOperative ISchemic Evaluation-3 Trial

Completed
NCT02004691Phase 2

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Completed
NCT04912518Not Applicable

Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

Recruiting
NCT03926728Phase 1

Safety and Immunogenicity of a Chlamydia Vaccine CTH522

Completed
NCT06555146Not Applicable

Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

Not Yet Recruiting
NCT06414005Phase 2

A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear

Recruiting
NCT06419686Phase 1

The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

Recruiting
NCT03090776Early Phase 1

Prevention of Post Mastectomy With Intraoperative Ketamine

Unknown
NCT06252454Phase 2

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
89